Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jiayi, Shu"'
Autor:
Rongrong Liu, Yunhua Lv, Wenjie Sun, Min Li, Ningning Ge, Cheng Zhu, Yaxin Ding, Ziyu Liu, Ruixue Ma, Yuxiao Huang, Shiyuan Hou, Qikang Ying, Tianle Gu, Fang Wang, Lingling Nie, Youchun Wang, Weijin Huang, Jiayi Shu, Xingan Wu
Publikováno v:
Virus Research, Vol 334, Iss , Pp 199149- (2023)
Due to the global resurgence of hemorrhagic fever with renal syndrome (HFRS), more attention is being focused on this dangerous illness. In China and Korea, the only vaccines available are the virus-inactivated vaccine against Hantaan virus (HTNV) or
Externí odkaz:
https://doaj.org/article/9af401a2f29744ba8cb5eb069f0d9052
Autor:
Rongrong Liu, Ruixue Ma, Ziyu Liu, Haifeng Hu, Jiayi Shu, Peizhen Hu, Junjun Kang, Yusi Zhang, Mingwei Han, Xiaoxiao Zhang, Yiting Zheng, Qikang Ying, Shiyuan Hou, Wenqiu Wang, Fang Wang, Ning Cheng, Yan Zhuang, Jianqi Lian, Xia Jin, Xingan Wu
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-10 (2021)
Rongrong Liu et al. find that Hantaan virus, a common cause of hemorrhagic fever with renal syndrome (HFRS) in China, can infect CD8+ T cells and that these cells can support the full viral replication cycle. They also see an association between CD8+
Externí odkaz:
https://doaj.org/article/5bc584b61789445782cbe26f90784bc1
Autor:
Rui Yu, Xiaohong Li, Peng Zhang, Minghao Xu, Jitong Zhao, Jingjing Yan, Chenli Qiu, Jiayi Shu, Shuo Zhang, Miaomiao Kang, Xiaoyan Zhang, Jianqing Xu, Shuye Zhang
Publikováno v:
Virologica Sinica (16740769); Jun2024, Vol. 39 Issue 3, p422-433, 12p
Autor:
Yue Zhang, Hu Yan, Xian Li, Dihan Zhou, Maohua Zhong, Jingyi Yang, Bali Zhao, Xuxu Fan, Jun Fan, Jiayi Shu, Mengji Lu, Xia Jin, Ejuan Zhang, Huimin Yan
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 1 (2022)
Chikungunya virus (CHIKV) is an emerging mosquito-transmitted alphavirus that leads to acute fever and chronic debilitating polyarthralgia. To date, the mechanism underlying chronic recurrent arthralgia is unknown. In the present study, newborn wild-
Externí odkaz:
https://doaj.org/article/dd33ac917af04c79bc4896c2d461563e
Autor:
Ruixue Ma, Xiaoxiao Zhang, Jiayi Shu, Ziyu Liu, Wenjie Sun, Shiyuan Hou, Yunhua Lv, Qikang Ying, Fang Wang, Xia Jin, Rongrong Liu, Xingan Wu
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Hantaan virus (HTNV) infects humans and causes hemorrhagic fever with renal syndrome (HFRS). The development of well-characterized animal models of HFRS could accelerate the testing of vaccine candidates and therapeutic agents and provide a useful to
Externí odkaz:
https://doaj.org/article/51e507cf59924827a556d3a198159637
Autor:
Rongrong Liu, Hongwei Ma, Jiayi Shu, Qiang Zhang, Mingwei Han, Ziyu Liu, Xia Jin, Fanglin Zhang, Xingan Wu
Publikováno v:
Frontiers in Microbiology, Vol 10 (2020)
Hantaviruses (HVs) are rodent-transmitted viruses that can cause hantavirus cardiopulmonary syndrome (HCPS) in the Americas and hemorrhagic fever with renal syndrome (HFRS) in Eurasia. Together, these viruses have annually caused approximately 200,00
Externí odkaz:
https://doaj.org/article/51f2e5397a9447e9a14803d5c21f32f2
Publikováno v:
Vaccines, Vol 9, Iss 12, p 1408 (2021)
TFPR1 is a novel adjuvant for protein and peptide antigens, which has been demonstrated in BALB/c mice in our previous studies; however, its adjuvanticity in mice with different genetic backgrounds remains unknown, and its adjuvanticity needs to be i
Externí odkaz:
https://doaj.org/article/a0188cbb92ad4111a205c166d150f2bc
Autor:
Ning Cheng, Jian-Qi Lian, Peizhen Hu, Yiting Zheng, Rongrong Liu, Fang Wang, Junjun Kang, Yan Zhuang, Shiyuan Hou, Zhang Xiaoxiao, Jiayi Shu, Wenqiu Wang, Haifeng Hu, Yusi Zhang, Mingwei Han, Ying Qikang, Ruixue Ma, Ziyu Liu, Xia Jin, Xingan Wu
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-10 (2021)
Hantaan viruses (HTNVs) are zoonotic pathogens transmitted mainly by rodents and capable of infecting humans. Increasing knowledge of the human response to HTNV infection can guide the development of new preventative vaccines and therapeutic strategi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c5985d632f29acd9f274055629acedc
https://doaj.org/article/5bc584b61789445782cbe26f90784bc1
https://doaj.org/article/5bc584b61789445782cbe26f90784bc1
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184207 (2017)
Human immunodeficiency (HIV) infection is a leading global health problem that causes approximately one million deaths each year. Although antiretroviral therapy can slow down the disease progression and improve the quality of life of infected indivi
Externí odkaz:
https://doaj.org/article/c07b1e4a0a714c19a23cf2ed773f5f6b
Autor:
Yiqing Zhou, Yongtao Sun, Shigang Yin, Jianqing Xu, Jiayi Shu, Jianhui Li, Lubin Jiang, Wei Shen, Haitao Liu, Xia Jin, Zhenghui Huang, Yan Zhuang
Publikováno v:
Vaccine. 38:2913-2924
Introduction CD4+ T cells are essential for inducing optimal CD8+ T cell and antibody-producing B cell responses and maintaining their long-term immunological memory. Therefore, CD4+ T cells are a critical component in HIV vaccine development. Due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81354423ff7a1b296ef4538959134795
https://doi.org/10.1016/j.vaccine.2020.02.069
https://doi.org/10.1016/j.vaccine.2020.02.069